Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  didemnin B
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 25 for your search:
Start Over
Phase II Master Protocol for New Agents in the Treatment of Advanced Colorectal Cancer --- Didemnin B (Summary Last Modified 05/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-86I3, NCI-T86-0292D, T86-0292
Phase II Study of Chemotherapy with Didemnin B in Patients with Advanced, Measurable Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-87021, NCI-T87-0071C, T87-0071
Phase I/II Study of Chemotherapy with Didemnin B in Patients with non-Small Cell Lung Cancer (Summary Last Modified 08/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-87027, NCI-T87-0074C, T87-0074
Phase II Chemotherapy with Didemnin B in Patients with Small Cell Lung Cancer (Summary Last Modified 11/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-87028, NCI-T87-0073C, T87-0073
Phase II Chemotherapy with Didemnin B for Patients with Metastatic Breast Cancer (Summary Last Modified 12/90)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-87039, NCI-T87-0108C, T87-0108
Phase II Chemotherapy with Didemnin B in Patients with Metastatic Adenocarcinoma of the Kidney (Summary Last Modified 03/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8728
Phase II Chemotherapy with Didemnin B in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 09/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8787A, NCI-T87-0193C, T87-0193
Phase II Chemotherapy with Didemnin B in Patients with Advanced Transitional Cell Carcinoma of the Bladder, Ureter, and Renal Pelvis (Summary Last Modified 10/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-87U3, NCI-T87-0206D, T87-0206
Phase II Chemotherapy with Didemnin B in Patients with Advanced Malignant Melanoma (Summary Last Modified 07/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-PB-687, EST-P-B687
Phase II Chemotherapy with Didemnin B in Patients with Disseminated Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8754
Phase II Chemotherapy with Intravenous Didemnin B in Patients with Advanced non-Small Cell Lung Carcinoma (Summary Last Modified 05/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: ICC-88L1, NCI-T88-0123D, T88-0123
Phase II Master Protocol for Advanced, Recurrent Pelvic Gynecologic Malignancies: Didemnin B (Summary Last Modified 04/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-26EE
Phase II Study of Didemnin B in Patients with Recurrent or Refractory Multiple Myeloma (Summary Last Modified 09/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8812, CALGB-8812
Phase II Study of Didemnin B in Patients with Recurrent or Refractory Anaplastic Astrocytoma or Glioblastoma Multiforme (Summary Last Modified 09/90)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NYMC-T88-0213, NCI-T88-0213N, T88-0213
Phase II Study of Didemnin B in Patients with Previously Treated non-Hodgkin's Lymphoma (Summary Last Modified 08/94)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: EST-1489
Phase II Master Protocol for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix --- Didemnin B (Summary Last Modified 05/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: GOG-76P
Phase II Study of Didemnin B in Adult Patients with Primary CNS Gliomas (Summary Last Modified 08/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9110
Phase II Study of Didemnin B in Patients with Advanced Sarcomas (Summary Last Modified 12/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: DFCI-91003, NCI-T91-0008D, T91-0008
Phase II Study of Didemnin B in Patients with Stage III/IV Favorable Histology Lymphoma Previously Untreated with Systemic Therapy (Summary Last Modified 11/93)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CAN-NCIC-IND78, NCI-T93-0081O, T93-0081, IND78
Phase I Chemotherapy with Didemnin B in Patients with Refractory Solid Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UTHSC-83405222, NCI-T84-0302W, T84-0302
Phase I Chemotherapy with Didemnin B in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-T84-0464W
Phase I Study of Chemotherapy with Didemnin B in Patients with Malignant Solid Tumors or Lymphomas (Summary Last Modified 12/89)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: CAN-NCIC-IND36, NCI-T85-0247W, T85-0247, IND36
Start Over